Folic acid supplementation doesn't boost cancer risk, analysis finds

01/28/2013 | Reuters

An examination of 13 trials involving nearly 50,000 individuals found no significant difference in the incidence of cancer between those who received folic acid supplements for five years and those who took placebos. Folic acid was not associated with a greater likelihood of developing certain types of cancer, either, including cancers of the colon, prostate, lung or breast.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT